Education
About Us
Working with TipRanks
Follow Us
Joseph Basile Insider Profile
4 Followers
Joseph Basile, Director at Neuren Pharmaceuticals Limited, holds 48.21K shares in Neuren Pharmaceuticals Limited (Ticker: NURPF). Most recently, Joseph Basile Bought 12,300 shares of Neuren Pharmaceuticals Limited on Mar 06, 2026 for an estimated value of $151.78K.
Joseph Basile Neuren Pharmaceuticals Limited (NURPF)Director
Neuren Pharmaceuticals Limited (NURPF)
Director
Ranked #31,240 out of 106,324 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Joseph Basile holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 16, 2025 - Today
Return:+33.80%
The most profitable trade made by Joseph Basile
Joseph Basile's Trading History
List of latest transactions for each holding click on a transaction to see Joseph Basile's performance on stock
You May Also Like
Joseph Basile insider profile FAQ
What is the percentage of profitable transactions made by Joseph Basile?
The percentage of profitable transactions made by Joseph Basile is 60%.
What is the average return per transaction made by Joseph Basile?
The average return per transaction made by Joseph Basile is 7.50%.
What stocks does Joseph Basile hold?
Joseph Basile holds: NURPF stocks.
What was Joseph Basile’s latest transaction?
Joseph Basile latest transaction was an Informative Buy of $151.78K.
What was Joseph Basile's most profitable transaction?
Joseph Basile’s most profitable transaction was an Informative Buy of NURPF stock on April 16, 2025. The return on the trade was 33.80%.
What is Joseph Basile's role in Neuren Pharmaceuticals Limited?
Joseph Basile's role in Neuren Pharmaceuticals Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.